These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
671 related articles for article (PubMed ID: 28438638)
21. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice. Nadeem A; Ahmad SF; Al-Harbi NO; Attia SM; Bakheet SA; Ibrahim KE; Alqahtani F; Alqinyah M Behav Brain Res; 2019 May; 364():213-224. PubMed ID: 30790585 [TBL] [Abstract][Full Text] [Related]
23. The potent immunomodulatory compound VGX-1027 regulates inflammatory mediators in CD4 Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alasmari F; Alasmari AF; Al-Kharashi LA; Al-Qahtani QH; Attia SM Life Sci; 2019 Nov; 237():116930. PubMed ID: 31610190 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of tyrosine kinase signaling by tyrphostin AG126 downregulates the IL-21/IL-21R and JAK/STAT pathway in the BTBR mouse model of autism. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alsanea S; Al-Hosaini KA; Mahmood HM; Alzahrani MZ; Attia SM Neurotoxicology; 2020 Mar; 77():1-11. PubMed ID: 31811869 [TBL] [Abstract][Full Text] [Related]
25. The Exposure to Lead (Pb) Exacerbates Immunological Abnormalities in BTBR T Assiri MA; Albekairi TH; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Shahid M; Aldossari AA; Almutairi MM; Almanaa TN; Alwetaid MY; Ahmad SF Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003408 [TBL] [Abstract][Full Text] [Related]
26. Resveratrol Improves Neuroimmune Dysregulation Through the Inhibition of Neuronal Toll-Like Receptors and COX-2 Signaling in BTBR T Ahmad SF; Ansari MA; Nadeem A; Alzahrani MZ; Bakheet SA; Attia SM Neuromolecular Med; 2018 Mar; 20(1):133-146. PubMed ID: 29468499 [TBL] [Abstract][Full Text] [Related]
27. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705 [TBL] [Abstract][Full Text] [Related]
28. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1. Brunsing RL; Prossnitz ER Immunology; 2011 Sep; 134(1):93-106. PubMed ID: 21722102 [TBL] [Abstract][Full Text] [Related]
29. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863 [TBL] [Abstract][Full Text] [Related]
30. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation. Lin YC; Lin YC; Wu CC; Huang MY; Tsai WC; Hung CH; Kuo PL Oncotarget; 2017 Jan; 8(5):7559-7571. PubMed ID: 27926504 [TBL] [Abstract][Full Text] [Related]
32. Increased CD4 Ma YH; Zhang J; Chen X; Xie YF; Pang YH; Liu XJ World J Gastroenterol; 2016 Nov; 22(42):9356-9367. PubMed ID: 27895423 [TBL] [Abstract][Full Text] [Related]
33. Cadmium exposure exacerbates immunological abnormalities in a BTBR T Albekairi TH; Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almanaa TN; Alwetaid MY; Alqinyah M; Alnefaie HO; Ahmad SF J Neuroimmunol; 2024 Jan; 386():578253. PubMed ID: 38064869 [TBL] [Abstract][Full Text] [Related]
34. Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17 Su Y; Wang Q; Yang B; Wu L; Cheng G; Kuang H Clin Exp Immunol; 2017 Oct; 190(1):40-53. PubMed ID: 28617942 [TBL] [Abstract][Full Text] [Related]
35. Resveratrol treatment attenuates chemokine receptor expression in the BTBR T+tf/J mouse model of autism. Bakheet SA; Alzahrani MZ; Nadeem A; Ansari MA; Zoheir KMA; Attia SM; Al-Ayadhi LY; Ahmad SF Mol Cell Neurosci; 2016 Dec; 77():1-10. PubMed ID: 27693537 [TBL] [Abstract][Full Text] [Related]
37. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism. Alomar HA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Hussein MH; Alqarni SA; Ahmad SF J Neuroimmunol; 2023 Apr; 377():578069. PubMed ID: 36931207 [TBL] [Abstract][Full Text] [Related]
38. The Role of Nicotinic Receptors in the Attenuation of Autism-Related Behaviors in a Murine BTBR T + tf/J Autistic Model. Mahmood HM; Aldhalaan HM; Alshammari TK; Alqasem MA; Alshammari MA; Albekairi NA; AlSharari SD Autism Res; 2020 Aug; 13(8):1311-1334. PubMed ID: 32691528 [TBL] [Abstract][Full Text] [Related]
39. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]